Sebastien Jochmans

Dr. Sebastien Jochmans

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2017 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
RRRené Robert
René Robert
AGAmélie Le Gouge
Amélie Le Gouge
NKNancy Kentish-Barnes
Nancy Kentish-Barnes
ACAlice Cottereau
Alice Cottereau
BGBruno Giraudeau
Bruno Giraudeau
JRJean Reignier
Jean Reignier

20 August 2018 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
FGFor the Hopeful Study Group
For the Hopeful Study Group
DCDamien Contou
Damien Contou
RSRomain Sonneville
Romain Sonneville
FCFlorence Canouï‐Poitrine
Florence Canouï‐Poitrine
GCGwenhaël Colin
Gwenhaël Colin
NPNicolas de Prost
Nicolas de Prost

6 November 2016 in Critical Care
Verified
Journal Article
Open access
PDF file
DCDamien Contou
Damien Contou
DRDamien Roux
Damien Roux
SJSebastien Jochmans
Sebastien Jochmans
RCRémi Coudroy
Rémi Coudroy
EGEmmanuel Guérot
Emmanuel Guérot
NPNicolas de Prost
Nicolas de Prost
The lack of a patent source of infection after 24 hours of management of shock considered septic is a common and disturbing scenario. We aimed to determine the prevalence and the causes of shock with no diagnosis 24 hours after its onset, and to compare the outcomes of patients with early-confirmed septic shock to those of others. We conducted a pragmatic, prospective, multicenter observational cohort study in ten intensive care units (ICU) in France. We included all consecutive patients admitted to the ICU with suspected septic shock defined by clinical suspicion of infection leading to antibiotic prescription plus acute circulatory failure requiring vasopressor support. A total of 508 patients were admitted with suspected septic shock. Among them, 374 (74 %) had early-confirmed septic shock, while the 134 others (26 %) had no source of infection identified nor microbiological documentation retrieved 24 hours after shock onset. Among these, 37/134 (28 %) had late-confirmed septic shock diagnosed after 24 hours, 59/134 (44 %) had a condition mimicking septic (septic shock mimicker, mainly related to adverse drug reactions, acute mesenteric ischemia and malignancies) and 38/134 (28 %) had shock of unknown origin by the end of the ICU stay. There were no differences between patients with early-confirmed septic shock and the remainder in ICU mortality and the median duration of ICU stay, of tracheal intubation and of vasopressor support. The multivariable Cox model showed that the risk of day-60 mortality did not differ between patients with or without early-confirmed septic shock. A sensitivity analysis was performed in the subgroup (n = 369/508) of patients meeting the Sepsis-3 definition criteria and displayed consistent results. One quarter of the patients admitted in the ICU with suspected septic shock had no infection identified 24 hours after its onset and almost half of them were eventually diagnosed with a septic shock mimicker. Outcome did not differ between patients with early-confirmed septic shock and other patients.

1 June 2016 in Resuscitation
Verified
Journal Article
Closed access
JCJonathan Chelly
Jonathan Chelly
NDNicolas Deye
Nicolas Deye
JGJean-Pierre Guichard
Jean-Pierre Guichard
DVDominique Vodovar
Dominique Vodovar
LVLy Vong
Ly Vong
MMMerhan Monchi
Merhan Monchi

24 May 2020 in Annals of Intensive Care
Verified
Journal Article
Open access
PDF file
SJSebastien Jochmans
Sebastien Jochmans
SMSandie Mazerand
Sandie Mazerand
JCJonathan Chelly
Jonathan Chelly
FPFranck Pourcine
Franck Pourcine
OSOumar Sy
Oumar Sy
MMMehran Monchi
Mehran Monchi
Prone position (PP) is highly recommended in moderate-to-severe ARDS. However, the optimal duration of PP sessions remains unclear. We searched to evaluate the time required to obtain the maximum physiological effect, and to search for parameters related to patient survival in PP. It was a prospective, monocentric, physiological study. We included in the study all prone-positioned patients in our ICU between June 2016 and January 2018. Pulmonary mechanics, data from volumetric capnography and arterial blood gas were recorded before prone positioning, 2 h after proning, before return to a supine position (SP) and 2 h after return to SP. Dynamic parameters were recorded before proning and every 30 min during the session until 24 h. 103 patients (ARDS 95%) were included performing 231 PP sessions with a mean length of 21.5 ± 5 h per session. They presented a significant increase in pH, static compliance and PaO2/FiO2 with a significant decrease in PaCO2, Pplat, phase 3 slope of the volumetric capnography, PetCO2, VD/VT-phy and ΔP. The beneficial physiological effects continued after 16 h of PP and at least up to 24 h in some patients. The evolution of the respiratory parameters during the first session and also during the pooled sessions did not find any predictor of response to PP, whether before, during or 2 h after the return in SP. PP sessions should be prolonged at least 24 h and be extended in the event that the PaO2/FiO2 ratio at 24 h remains below 150, especially since no criteria can predict which patient will benefit or not from it. Trial registration The trial has been registered on 28 June 2016 in ClinicalTrials.gov (NCT 02816190) (https://clinicaltrials.gov/ct2/show/NCT02816190?term=propocap&rank=1).

13 February 2017 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Closed access
PDF file
JCJérôme Cecchini
Jérôme Cecchini
STSamuel Tuffet
Samuel Tuffet
RSRomain Sonneville
Romain Sonneville
MFMuriel Fartoukh
Muriel Fartoukh
JMJulien Mayaux
Julien Mayaux
NPNicolas de Prost
Nicolas de Prost
Background: Legionnaires’ disease (LD) is an important cause of community-acquired pneumonia with high mortality rates in the most severe cases. Objectives: To evaluate the effect of antimicrobial strategy on ICU mortality. Methods: Retrospective, observational study including patients admitted to 10 ICUs for severe community-acquired LD over a 10 year period (2005–15) and receiving an active therapy within 48 h of admission. Patients were stratified according to the antibiotic strategy administered: (i) fluoroquinolone-based versus non-fluoroquinolone-based therapy; and (ii) monotherapy versus combination therapy. The primary endpoint was in-ICU mortality. A multivariable Cox model and propensity score analyses were used. Results: Two hundred and eleven patients with severe LD were included. A fluoroquinolone-based and a combination therapy were administered to 159 (75%) and 123 (58%) patients, respectively. One hundred and forty-six patients (69%) developed acute respiratory distress syndrome and 54 (26%) died in the ICU. In-ICU mortality was lower in the fluoroquinolone-based than in the non-fluoroquinolone-based group (21% versus 39%, P = 0.01), and in the combination therapy than in the monotherapy group (20% versus 34%, P = 0.02). In multivariable analysis, a fluoroquinolone-based therapy, but not a combination therapy, was associated with a reduced risk of mortality [HR = 0.41, 95% CI 0.19–0.89; P = 0.02]. Conclusions: Patients with severe LD receiving a fluoroquinolone-based antimicrobial regimen in the early course of management had a lower in-ICU mortality, which persisted after adjusting for significant covariates.